Liposarcoma of the Pelvis and Soft Tissues

El-Abbassi, Sarah; Sfaoua, H.; Kebdani, Tayeb; Benjaafar, Noureddine

doi:10.21767/2254-6081.1000i31

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[3] [4] Primary malignancies of the POD are exceedingly rare. [5] On extensive search of current English literature by the authors, we identified around 40 cases of primary malignancies of the Pouch of Douglas. The first case was reported by Dockerty et al (1954).…”

Section: Discussionmentioning

confidence: 99%

Pouch of Douglas Liposarcoma—A Rarity

Rajkumar¹,

Aluru²,

Anirudh³

et al. 2021

OJOG

View full text Add to dashboard Cite

Introduction: This case report is one of a fairly common tumour in an extremely uncommon anatomic location. Statistically liposarcoma is the commonest type of soft issue malignancy, but publications of such a tumour arising from the pouch of Douglas (POD) to involve the uterus, are very few and far between. Case details: A 52-year-old woman presented with a mass in the lower abdomen, post-menopausal vaginal bleeding, and lower abdominal discomfort. Investigations revealed a large pelvic tumour that was attached to the posterior wall of a bulky uterus. There was no evidence of dissemination of the tumour to distant sites, and a laparotomy was performed. A massive soft tissue tumour occupied the POD. The tumour was dissected out from the surrounding structures, and the uterus and its appendages were removed in to. The histopathological examination revealed a liposarcoma of the pleomorphic type which was arising from the pouch of Douglas (POD), and was attached to the posterior wall of the uterus. Extensive leiomyomatous changes were seen in the uterus. Immunohistochemistry confirmed the liposarcoma to be of pleomorphic type. Conclusion: This case report is being published for its rarity and to illuminate the specific issues in the treatment of this ubiquitous tumour in an unusual site. The involvement of a Multidisciplinary Team (MDT) helps to choose the optimal combination of cytoreductive surgery, chemotherapy, and radiation for a given case with a POD malignancy.

show abstract

Section: Discussionmentioning

confidence: 99%